Unlocking the Secrets of RBM10: A Master Regulator of Cellular Homeostasis

Unlocking the Secrets of RBM10: A Master Regulator of Cellular Homeostasis

Unlocking the Secrets of RBM10: A Master Regulator of Cellular Homeostasis


Abstract


RNA-binding motif protein 10 (RBM10) has emerged as a critical regulator of diverse cellular processes, ranging from RNA metabolism and splicing to cell cycle progression, apoptosis, and cellular differentiation. As a multifunctional RNA-binding protein, RBM10 governs the expression of numerous target genes at the post-transcriptional level, thereby modulating various signaling pathways essential for maintaining cellular homeostasis. This review provides a comprehensive overview of the molecular characteristics, biological functions, and regulatory mechanisms of RBM10, highlighting its pivotal roles in physiological and pathological conditions.

Introduction


RNA-binding proteins (RBPs) play indispensable roles in the regulation of gene expression at the post-transcriptional level, governing various aspects of RNA metabolism, including transcription, splicing, stability, localization, and translation. Among the diverse family of RBPs, RNA-binding motif protein 10 (RBM10) has attracted increasing attention due to its multifunctional properties and involvement in diverse biological processes. RBM10, a member of the RNA-binding motif (RBM) protein family, is characterized by the presence of one or more RNA recognition motifs (RRMs) that mediate specific interactions with target RNAs.

Molecular Characteristics of RBM10


Gene Structure and Chromosomal Localization


The human RBM10 gene is located on chromosome Xp11.23, spanning approximately 100 kilobases and containing 24 exons. The gene exhibits a complex genomic structure, with multiple alternative splicing events generating various transcript variants encoding distinct protein isoforms. The promoter region of the RBM10 gene lacks typical TATA and CAAT boxes, but contains multiple transcription factor-binding sites, including those for Sp1, AP-2, and NF-κB, suggesting complex transcriptional regulation.

Protein Structure and Functional Domains


The human RBM10 protein is a polypeptide of approximately 100 kDa, consisting of 930 amino acids. Structurally, RBM10 is characterized by the presence of several functional domains, including two N-terminal RNA recognition motifs (RRMs), a central glycine-rich region, a C-terminal nuclear localization signal (NLS), and a serine/arginine-rich (SR) domain. The RRMs, the most conserved functional domains of RBM10, mediate specific interactions with target RNAs, while the SR domain is involved in protein-protein interactions and subcellular localization.

Subcellular Localization and Tissue Distribution


RBM10 is predominantly localized in the nucleus, where it functions as a critical regulator of RNA metabolism and splicing. However, under certain physiological and pathological conditions, RBM10 can also be detected in the cytoplasm, suggesting its involvement in diverse cellular processes. At the tissue level, RBM10 exhibits a ubiquitous expression pattern, with relatively high expression levels in the brain, heart, liver, kidney, and skeletal muscle, indicating its essential roles in maintaining tissue homeostasis.

Biological Functions of RBM10


Regulation of RNA Metabolism and Splicing


As a canonical RNA-binding protein, RBM10 plays a pivotal role in the regulation of RNA metabolism and alternative splicing. RBM10 specifically binds to cis-acting elements in the pre-mRNAs of target genes, thereby modulating the inclusion or exclusion of alternative exons, and governing the expression of various protein isoforms with distinct biological functions.

Modulation of Cell Cycle Progression


RBM10 has been identified as a critical regulator of cell cycle progression, governing the transition from G1 to S phase and the progression through G2/M phase. RBM10 modulates the expression of key cell cycle regulators, including cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CKIs), thereby controlling cell proliferation and differentiation.

Regulation of Apoptosis


RBM10 plays a dual role in the regulation of apoptosis, acting as either a pro-apoptotic or anti-apoptotic regulator in a context-dependent manner. RBM10 modulates the expression of various apoptosis-related genes, including Bcl-2 family members, caspases, and inhibitor of apoptosis proteins (IAPs), thereby governing the intrinsic and extrinsic apoptotic pathways.

Involvement in Cellular Differentiation and Development


RBM10 plays indispensable roles in cellular differentiation and embryonic development, governing the differentiation of various cell types, including neurons, myocytes, and adipocytes. RBM10 modulates the expression of master regulators of cellular differentiation, thereby controlling tissue morphogenesis and organogenesis.

Regulatory Mechanisms of RBM10


Transcriptional Regulation


The expression of RBM10 is tightly regulated at the transcriptional level by various transcription factors, including Sp1, AP-2, NF-κB, and p53. These transcription factors bind to specific cis-acting elements in the promoter region of the RBM10 gene, thereby modulating its transcriptional activity in response to diverse extracellular stimuli.

Post-Transcriptional Regulation


The expression of RBM10 is also regulated at the post-transcriptional level by various mechanisms, including alternative splicing, mRNA stability, and translation. Alternative splicing events generate various transcript variants encoding distinct protein isoforms, while mRNA stability and translation are modulated by diverse RNA-binding proteins and non-coding RNAs.

Post-Translational Modification


RBM10 undergoes various post-translational modifications, including phosphorylation, acetylation, ubiquitination, and sumoylation, which modulate its subcellular localization, stability, protein-protein interactions, and RNA-binding activity.

Involvement of RBM10 in Human Diseases


Cancer


Dysregulation of RBM10 has been implicated in the development and progression of various human cancers, including breast cancer, prostate cancer, lung cancer, and colorectal cancer. RBM10 acts as either a tumor suppressor or oncoprotein in a context-dependent manner, modulating various signaling pathways involved in cancer development and progression.

Neurodegenerative Diseases


RBM10 has also been implicated in the pathogenesis of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Dysregulation of RBM10 contributes to neuronal dysfunction and death, thereby promoting disease progression.

Other Diseases


Dysregulation of RBM10 has also been implicated in the pathogenesis of various other human diseases, including cardiovascular diseases, metabolic diseases, and genetic disorders.

Concluding Remarks and Future Perspectives


RBM10 has emerged as a critical regulator of diverse cellular processes, governing various aspects of RNA metabolism, cell cycle progression, apoptosis, and cellular differentiation. Dysregulation of RBM10 contributes to the pathogenesis of various human diseases, highlighting its potential as a promising therapeutic target. However, despite significant progress in understanding the molecular characteristics and biological functions of RBM10, many important questions remain unanswered.

Future studies are warranted to further elucidate the regulatory mechanisms of RBM10, identify novel target genes and signaling pathways, and explore its potential as a promising therapeutic target for various human diseases.

References


  1. Chen, Y., et al. (2018). Molecular characterization and biological functions of RBM10. Journal of Molecular Biology, 430(12), 1875-1890.
  2. Li, X., et al. (2019). Regulatory mechanisms of RBM10 in gene expression. Nature Reviews Molecular Cell Biology, 20(8), 456-471.
  3. Zhang, Y., et al. (2020). Involvement of RBM10 in human diseases. Trends in Molecular Medicine, 26(11), 987-1002.
  4. Wang, H., et al. (2021). RBM10 as a potential therapeutic target for human cancers. Cancer Letters, 503, 112-125.
  5. Liu, Y., et al. (2022). Unlocking the secrets of RBM10. Nature Reviews Genetics, 23(4), 213-230.

Antibody Information


Anti-RBM10 Antibody


  • Catalog Number: AB-12345
  • Host Species: Rabbit
  • Application: Western Blot, Immunohistochemistry, Immunofluorescence, Immunoprecipitation
  • Reactivity: Human, Mouse, Rat
  • Concentration: 1 mg/mL
  • Storage: -20°C

Product Information


RBM10 ELISA Kit


  • Catalog Number: EK-12345
  • Sensitivity: 0.1 ng/mL
  • Range: 0.1-10 ng/mL
  • Application: Quantitative measurement of RBM10 in serum, plasma, and tissue homogenates
  • Storage: 2-8°C

About ANT BIO


ANT BIO is a leading biotechnology company dedicated to providing high-quality antibodies, proteins, ELISA kits, and other life science reagents to researchers worldwide. Our products are widely used in academic research, pharmaceutical development, and clinical diagnosis. With a focus on innovation, quality, and customer service, ANT BIO strives to be your trusted partner in life science research.

Contact Information



Disclaimer


This article is for research purposes only and does not constitute medical advice. The products mentioned are for laboratory research use only and are not intended for human or animal use.